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PROPAGATION OF GROUP A COXSACKIE VIRUSES IN TISSUE CULTURES
II. Some Interactions Between Virus and Mammalian ColIst
In contrast with the 6 Group B Coxsackie viruses which readily induce a
cytopathic effect (CPE) in tissue cultures, many of the Group A viruses
have either failed to alter visibly cells propagated in cultural systems, or
have required "adaptation" for such an effect. In the course of studies made
during the last two years we have obtained CPE on primate cells cultured
in vitro for all except 7 serotypes among the 24 Group A viruses.
HISTORICAL RESUMI
In 1950, Slater and Syverton' noted that Group A, type 4 (Minnesota
strain) virus propagated through 24 successive passages in cultures of
minced embryonic mouse cells. Shortly thereafter Robbins et al.2 and
Riordan et al.' while engaged in studies of poliomyelitis commented on the
capacities of unidentified Group A viruses (type 9, and others) to produce
CPE on cultured primate cells. One of these strains (Wiederhold) produced
CPE in cultures of human cells originating from kidney, embryonic skin-
muscle, and uterine tissues. This strain also multiplied in cultures of
human embryonic brain tissue. In contrast, another strain (High Point,
type 4) multiplied in suspended cell cultures of human embryonic brain but
not in kidney or in skin-muscle or in embryonic intestinal tissues.' Shaw,'
studying strains belonging to 10 serotypes obtained growth (apparently
without CPE) of types 2 (8 passages) and type 4 (including Slater and
Syverton's type 4) strains in minced embryonic chick cells. Strains repre-
senting types 1, 3, 5, and 6 failed to grow. Stulberg' passaged type 1 virus
serially in cultures prepared from skeletal muscle of infant mice; however,
evidence of virus multiplication was not definitely established.
Since 1957 most of the in vitro studies on propagation of the Coxsackie
viruses have used cells obtained from primate species. Habel and Loomis
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and Johnsson and Lundmark8 obtained CPE with several Group A type 7
viruses on cells derived from monkeys and from human beings. Soon
thereafter, Sickles et al.' while adding 5 new serotypes (types 20-24) to the
Group A viruses noted that types 20, 20a, 20b, 21 and 23 produced CPE
during passage on primate cells. Lehmann-Grube and Syverton10'l obtained
in primary cultures of human amnion cells propagation with CPE for types
6, 9, 10, 11, 13, 14, 15, and 18; in 1959, Syverton sent us type 16 virus
which he and his associates had also propagated in vitro. Recently, Dunne-
backe and Maltern' also reported on the "adaptation" of type 10 on human
amnion cells. Lenahan and Wennere3 obtained CPE on amnion cells
with types 3, 8, 12, 17, and 24. Thus, within the last 10 years reports have
appeared in the literature on the propagation in tissue cultures of 22 of the
24 Group A Coxsackie viruses.
The advantages of utilizing Group A Coxsackie viruses propagated in
tissue cultures for work in progress in the University of Kansas became
evident during studies on preparation of type-specific reference antisera.
In studies with 24 prototypic viruses we have been able to propagate, with
associated CPE, 17 serotypes in either human amnionic or in other primate
cells cultivated in vitro. This report summarizes some of the biological
interactions associated with replication on mammalian cells of Group A
Coxsackie viruses.
MATERIALS AND METHODS
Viruses. The 24 Group A serotypes, and 2 subtypes (types 20a and 20b) * were made
available to us by Dr. Hildegaard Plager,** Division of Laboratories, New York
State Health Department, Albany, N. Y. The histories of the prototypic viruses',4'l'
are summarized in Table 1. Virus stocks used for inoculating tissue cultures were
derived from infected mice; however, 2 serotypes (20, 20a, and 21) had been passed
in tissue cultures, although subsequently each was maintained in weanling mice at
Albany.
Antisera. Dr. Plager also provided type-specific antisera. Some other type-specific
antisera were prepared by Syverton and associates; in addition, several prepared in
this laboratory were available.
Tissue cultures. The 9 tissues used in the study were obtained from human beings,
monkeys, and mice. Tissues were washed, minced, and "digested" with trypsin using
* Serotypes 20a and 20b are considered at this time to be subtypes of Group A, type
20 virus. The 26 viruses included in the study therefore have been considered as
belonging to 24 serotypes.
** We are indebted to Dr. Plager and to Dr. Gilbert Dalldorf, Sloan-Kettering
Institute for Cancer Research, Rye, New York, for making available all serotypes
except Vispo; the latter serotype (type 23) was made available to us by Dr. Italo
Archetti (Instituto Superiore di SanitA, Roma) while he was a member of the Section
for Virus Research.
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TABLE 1. RESUME OF ORIGINS AND PASSAGE HISTRIESS FOR 26 GROUP A
COXSACKIE VIRUSES
Tompkins
Fleetwood
Olson
Ala 4-CDC
Swartz
Gdula
Parker
Donovan
Bozek
Kowalik
Belgium 1
Texas 12
Flores
G 14 3
G 9
G 10
G 12
G 13
Dohi
IH $35
Tulane 1623
Cecil
9, 8
9, 6
5, S
5, 9
7, a
3, 8
6, 9
7,
18mo., 8
flies
23 mo., ?
1[ ,
2, a
2, 9
3,
2, 9
5, S
pool
3, S
25/2, 8
Kuykendall 17, a
Chulman
Vispo
Joseph
14,
2, a
3, S
History of origin
Kind of
Year
1947
1947
1948
1950
1949
Pt
of
1950
Pt
! 1951
1948
1952
1950
VP
1951
,,
1950
1952
1955
1951
1951
1952
1955
1955
1952
ii
pleu
hel
llness Geographic area N.Y.S.
P Coxsackie, N. Y. M1,Hs,M8s
Wilmington, Del. Mso
- New York State M47
? Alabama? >M18
? New York State M17
NP Silver Creek, N. Y. M27
NP? Rochester, N. Y. M1
NP Levittown, N. Y. M29
- Glen Cove, N. Y. M90
P? New York State M19
rodynia Belgium MI8
none Texas M1.
? Mexico M
none S. Africa M7
Pt MIS
,, ,, M16
P Japan M28
patitis New York State HE7HeLa5M17
NP? Bayou Bouif, La. HE3M,5
none
p
GI
NP
none
S. Africa
San Leandro, Cal.
New York State
Ancona, Italy
S. Africa
H
M19
IE4M17
MO
Mis
Accession numbers are those assigned these viruses by the New York State Department of Health.
Under strain: IH, infectious hepatitis. Under kind of illness: P, paralytic; NP, non-paralytic; GI, gastro-
intestinal; ?, unknown. Kinds of passages: M, suckling mice; H, infant hamster; HE, human embryonic
tissues; MK, monkey kidney; HA, human amnion. The investigators supplying many Group A serotypes
to the New York State Department of Health, as well as those recognized by Dalldorf and, Sickles, have
been published elsewhere.'-'-'
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Virus
Acces- Age,
Type cession no. Strain sex
Pasage in laboratory
1 48249
2 49190
3 49191
4 50246
5 5134
6 5011
7 50140
8 5010
9 50546
10 50548
11 52148
12 51204
13 5359
14 52113
15 52108
16 52109
17 52111
18 52112
19 53157
20 55166
20a 5536
20b 5721
21 55161
22 5630
23
24 5720
K.U.
Ml
Ml
Ml
M1L
ml
Ml
Had
Ml
Ml
Ml
Ml
Ml
Ml
Ml
Ml
Ml
Ml
Ml
Ml
M,
Ml
Ml
HA
Ml
MIKHA4
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methods previously described."-'7 The mediae- used from growth and maintenance of
each cell "type" are summarized in Table 2.
Measurements.
In tissue cultures. Each stock virus was inoculated into 3 or 4 cultures, depending
on availability, using 0.1 ml inoculum per culture (volume of maintenance medium
TABLE 2. CULTIVATION AND MAINTENANCE OF TISSUE CULTURES: MEDIUMS USED IN
RELATION To APPEARANCE OF CELLS
Medium used*
Kind of culture
Human amnion
" foreskin
" lung
" kidney
" , HeLa
" , KB
Monkey kidney
" testes
Mouse embryo
for growth pH for maintenance pH
199, + 20% Hs 7.0 199, + 0.5% Leh 7.3
", + 10% " 7.0 ", + " " 7.0
", + 20% " 7.0 Eagles' + 5% Ch.s 7.5
LG, + 5% Cs 7.4 199, + 0.5% Leh 7.2
YEM + 15% Hs 6.8 ", + 7.5% Cs 7.0
" + " " 6.8 " , + 7.5% Cs 7.0
LG + 2% Cs 7.0 hcAEm 7.4
B + 3% " 7.4 B + 3% Cs 7.6
199, + 20% Cs 7.5 199, + 2% Cs 7.6
Appearance of cells on indicated
days after inoculation**
No. of Days
tests 0-1 2-4 5-6 >7
27
5
4
E G
G F
G F
G
F
F
F
F
F
4 G F F F
14 G F F F
10 G F F P
12 E E E G
13 E E G F
9 G G F F
*The kinds of mediums are designated by abbreviations; details concerning composition of these mediums
are listed in the following references: Medium 199"; LG, lactalbumin growth medium19; YEM, yeast
extract medium + tryptose phosphate" 1; medium B'; Eagle's'; hcAEm, high cystine altered Eagle's
maintenance without any added serum.17 Hs, human serum; Cs, calf serum; Ch.s, chicken serum; Leh,
lactalbumin enzymatic hydrolysate; percentages refer to volume of serum or Leh present in medium.
** E, excellent; G, good; F, fair; P, poor. Excellent, indicates outgrowth of contiguous monolayers of
cells; poor, indicates peeling of cell sheet involving more than half the surface of the culture; the cells
remaining attached showed cytoplasmic granularity. Good and fair are intermediate gradings. Gradings
were obtained only for uninoculated control cultures entered in tests. pH entries are initial values when
medium was added to cells. Cultures were incubated at 37 + 0.50 C.
per culture was 1.5 ml). Inoculated tubes were returned to a drum and "rolled." If
CPE was not observed by the 7th ± 1 day, the fluid overlay from each culture was
harvested and pooled; this material constituted the inoculum for another set of cultures
of the corresponding cell type. Four or more passages were made before studies with
any cell line were terminated.
After the appearance of CPE, which was sometimes incomplete at first, passage was
continued until maximal CPE was obtained. At this level of passage, fluid overlays
were harvested and pooled for subsequent titration and specificity studies. For titration
purposes serial decimal dilutions of virus were made; each dilution was tested in 3 or
4 replicate cultures. TCD50 endpoints were determined by the Reed-Muench method."
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Serotypic specificity was ascertained by determining serum dilution endpoints (SDE's)
with serotypic antisera using approximately 100 TCDOO of virus. Inactivated sera
(560 for 30 minutes) were diluted serially in 4-fold steps; after addition of virus,
mixtures were incubated (37 C.') for 1 hour. Cultures inoculated with serum-virus
mixtures were observed for 7 days, or until appropriate endpoints were obtained in
control tubes inoculated with several dilutions of virus.
In suckling mice. Mouse torso suspensions which were obtained from mice previously
infected with designated serotypes as well as the fluid overlays harvested from tissue
cultures inoculated with corresponding serotypes were tested in newborn mice. Each
undiluted or diluted stock was tested in 8 mice (litters were randomized); each mouse
received 0.08 ml inoculum by intramuscular (0.04 ml) and intraperitoneal (0.04 ml)
routes. Mice were observed twice daily. Scores were based on illness, paralysis and
death occurring 36 hours after inoculation. One litter of uninoculated mice and one
other inoculated with phosphate buffered saline were included as controls in each
experiment.
Fluorescent antibody studies. Stock viruses were inoculated on monolayers of
human amnion cells previously grown on glass slips in Leighton tubes. On each of 3
consecutive days infected slip cultures were removed from the tubes; each was washed
twice with PBS prior to fixation in acetone. After drying (370 for 30 minutes). the
slips were stored at 40 until stained. Potent antiserum (SDE > 1: 1000/0.1 nml)
prepared in monkeys was conjugated with fluorescein isothiocyanate.'" After addition
of conjugated antiserum to the cell layer the slips were set (for 30 minutes) in a
petri dish containing wet cotton. The antiserum was removed by washing with saline
phosphate buffer, pH 7.0. The mount was viewed by ultra-violet microscopy using
Corning #5840 and Wratten 2B filters, and an Osram 200 watt light source.
RESULTS
VIRUSES PRODUCING CYTOPATHOGENIC EFFECT (CPE)
In human amnion cells.
Of the 26 Group A viruses entered in the study, including types 20a and
20b, a total of 18 produced CPE on passage in primary cultures of human
amnion cells. Of these, 14 viruses produced unequivocal CPE at first
passage, and 4 viruses (types 3, 8, 12, and 16) either failed to cause CPE
initially, or else cytopathic changes were equivocal. After several consecu-
tive passages, however, the latter viruses caused maximal CPE. Also
among these were 5 viruses which initially caused maximal cell destruction,
but thereafter, displayed a lesser CPE for several passages (see e.g. types
11 and 17); however, these 5 viruses after several additional passages
produced maximal CPE. Eight of the 26 Group A viruses have failed thus
far in our studies to produce CPE in amnion cells; some of these viruses
have been through 8 or more consecutive passages. Data pertaining to the
18 viruses propagable in human amnion cells are recorded in Table 3.
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Other human cell cultures.
Among the 8 viruses that failed to injure visibly amnion cells, only type
7 produced CPE on HeLa cells. None of the other 7 viruses (type 1, 2, 4,
5, 6, 19, and 22) produced CPE in any of the 5 cell lines listed in Table 4.
Among the 18 viruses that caused CPE on amnion cells four serotypes
(types 3, 8, 10, and 17) failed to cause CPE on any of the other human cell
lines entered in the 'study. Others, such as types 9, 12, and 23 produced
CPE on primary cultures of human cells, but not on continuous cultures of
HeLa or KB cells. Two strains (types 16 and 24) were cytopathic for
HeLa and KB, but were not cytopathic for kidney or skin cultures derived
from human beings. The 9 remaining viruses produced CPE on all lines
of human cells entered in these tests; the CPE caused by the type 14 on
cultures of human skin were of an equivocal nature.
Other primate cell cultures.
From monkeys. Six prototypic viruses produced CPE on either renal or
testicular cell cultures derived from monkeys. Four serotypes (types 9, 14,
16 and 23) produced CPE with both kinds of culture. Two viruses (types
7 and 10) however, produced CPE only on renal cells.
From mice. None of the 26 Group A viruses caused demonstrable CPE
on cultures prepared from mouse embryonic tissues (Tables 4 and 7).
NATURE OF VIRUS PROPAGATION
Kinds of CPE.
Human Amnion cells. Two major kinds of CPE were observed. The
majority of the Group A serotypes caused similar CPE. The first signs of
injury consisted of "plaques" containing rounded, or dendritic cells with
granular cytoplasm. The rates with which CPE advanced varied for differ-
ent serotypes (see Table 3). At the final stage most cells were sequestered,
rounded and dark in appearance. These rounded cells sloughed from the
glass, whereas some of the elongated type remained adherent. Several sero-
types (e.g. types 9, 20a, 21, and 23) produced CPE like that of polioviruses.
CPE advanced rapidly after onset; within 24 to 48 hours the sequestrated
cells lysed and fell from the glass, leaving nothing more than granular
debris. The differences between these 2 kinds of CPE on amnion cells are
illustrated in Figure 1.
Human skin. At onset of CPE, cells sequestrated, became rounded and
shrunken. The cytoplasm appeared granular. Sequestrated cells either lysed
or dropped off the glass surface leaving behind a granular residue.
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Human kidney. The reaction was similar to that obtained in human skin.
HeLa and KB cells. The kind of CPE resembled that generally obtained
in human amnion cultures.
Monkey kidney and testis. Onset of CPE was associated with appearance
of "plaques"; CPE advanced at irregular rates (Table 4); eventually the
rounded cells lysed or fell away from the cell sheet. For types 10, 14, and 16
rounded cells remained attached to the glass longer than others; for types
7, 9, and 23, CPE was rapid with extensive lysis of cells.
TABLE 5. COMPARATIVE SENSITIVITIES OF FOUR CULTURAL SYSTEMS FOR
MEASURING CONCENTRATIONS OF INFECTIOUS VIRUS
Infected Infected
Group A fluid TCDso in cultures of fluid
Coxsackie overlay type of overlay TCDso in cultures of
serotype from origin amnion from amnion MK KB
10 MK 2.8 4.3 amnion 4.7 3.2 <1.0
11 KB 1.5 3.3* " 4.0 <1.0 nd
16 nd nd " 3.7 2.5 2.5*
18 KB 3.0 2.3* " -5.0 nd 1.7*
24 HeLa <1.0 <1.0 " 4.5 <1.0 2.5*
*Incomplete CPE in cultures inoculated with 10 to 100 TCDW.
Infectivity titers.
The titers (TCD50/0.1 ml) obtained in fluid overlays harvested from
cultures showing CPE are entered in Tables 3 and 4. The titers obtained
from amnion cells ranged between 10'5 (type 17) to 10" (type 9). Lower
titers (often >10 fold) were often obtained with fluids harvested from in-
fected cultures of KB, HeLa, and monkey testicular cells inoculated with
the same serotype. On the other hand, only one (type 10) of the 6 sero-
types producing CPE on renal cells (Table 4) gave a titer significantly
lower than was obtained in amnion cells.
Specificity of viruses
Each Group A virus propagated in amnion HeLa, KB, and monkey
renal or testicular cultures, was neutralized by homologous type-specific
antisera. The SDE's obtained for Group A viruses propagated in amnion
cells appear in Table 3.
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Comparative sensitivities of cell lines for quantitative studies
The data summarized in Tables 3 and 4 indicated that infectivity measure-
ments varied independently for several different serotypes (e.g. types 15
and 24) and for the cultural system in which they were propagated. Group
A viruses producing CPE in primary cultures originating from human and
simian sources provided, with but several exceptions, similar infectivity end-
points. Most TCD50 endpoints ranged in values within experimental error
in these relatively crude assays. However, yields obtained with types 11
TABLE 6. COMPTIVE LDao ENDPOINTS OBTAINED IN MICE FOR SIX
VIRUSES BEFORE AND AFTER PASSAGE IN AMNION CELLS
Infected amnionic fluid
Group A Mouse torso 4th passage last passage
Coxsackie Mouse* Amnion Mouse Amnion No. Mouse Amnion
serotype LDso TCDso LDso TCD,o passages LDso TCDso
3 8.7 <1.0 1.1 nd 12 e0.7 4.7
8 8.3 <1.0 <1.0 " 7 <0.3 3.8
12 7.9 <1.0 2.6 6 12.0 4.7
14 8.2 2.8 1.3 4.3 4 1.4 4.3
17 6.8 1.4 <1.0 nd 8 1.0 3.5
24 6.9 1.4 <1.0 " 9 <0.3 4.5
All endpoints were determined on basis of 0.1 ml inoculum.
* Mouse LDw values may differ from entries in Table 4 because several different
stock virus pools were used, for passage in tissue cultures.
and 20a in KB, and with type 24 in HeLa cells were significantly lower
than for other cell lines entered in the study.
In order to explain whether the differences were due to inefficiency of
virus replication, or insensitivity of the cultural systems 5 serotypes pro-
ducing CPE in 4 cultural systems were retested in heterologous tissue
culture systems. The results of these tests appear in Table 5. Some cell
types (HeLa and type 24) were incapable of producing the same amount of
virus produced at the same level of passage in amnion cells. Other cell
types (renal cells and type 10) were capable of such production. But, in
general, and with an appreciation of the inequities of systems employed in
these tests, amnion cells almost always provided a better substrate than
others both for growth and for measuring maximally the amounts of virus
present in fluid overlays.
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PATHOGENICITY FOR MICE OF GROUP A VIRUSES PROPAGATED IN AMNIOTIC CELLS
Group A viruses propagated in human amnion cells acquired significant
reduction in virulence for mice. By the 4th passage high concentrations of
infected tissue culture fluids were required in order to cause either paralysis
or death in 50 per cent or more of mice. Additional passages of these viruses
in amnion cells failed to significantly change the LD5o endpoints. At the
last passage levels given in the table the number of viral particles required
TABLE 7. FAILURE TO DETECT CPE IN NINE KINDS OF TISSUE CULTURES
DURING SERIAL PASSAGES OF SEVEN GROUP A COXSACKIE VMIUSES
(Origin, infected mouse torso.)
Kind of culture
Human Monkey Mouse
Type* amnion kidney skin lung HeLa KB kidney testis embryo
Al 0 0 0 0 0 0 0 0 0
A2 0 0 0 0 0 0 0 0 0
A4 0 0 0 0 0 0 0 0 0
A4 0 0 0 0 0 0 0 0 0
A6 0 0 0 0 0 0 0 0 0
A19 0 0 0** 0 0 0 0 0 0
A22 0 0 0** 0 0 0 0 0 0
* These serotypes have been passaged serially in human amnion, 8x; mouse embryo,
5x; human lung, 3x; and for all others, 4x. Another attempt to obtain CPE for these
viruses was made by adding virus to cells in suspension. These exposed cells formed
monolayers without plaque formation or occurrence of CPE.
** Questionable CPE at 4th passage on monolayers of human skin.
to produce disease in mice ranged between 320 and 10,000 TCD50 (Table
6). The reduction in virulence for mice of type 12 was less than for the 5
other viruses entered in the tests.
Titers of virus derived from infant mice and titrated in these animals
were almost always greater than titers derived from amnion cells and
titrated also therein. Amnion cells were not as sensitive as suckling mice
for measuring the virus "load" present in infected mouse torso (Table 6).
GROUP A VIRUSES NOT YET ESTABLISHED IN TISSUE CULTURES
The 7 Group A viruses which have not produced CPE in tissue cultures
thus far are types 1, 2, 4, 5, 6, 19, and 22. These serotypes have now been
passaged at least 3 and as many as 8 times in the 9 cultural systems listed
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in Table 7. Excepting for very questionable onset of CPE in cultures of
human skin with types 19 and 22 the results have been uniformly negative.
In order to determine whether virus replication occurred without causing
CPE in cultures of human amnionic and monkey renal cells, fluid overlays
obtained with these 7 and with 16 other Group A viruses were repassed in
several heterologous cellular systems. These same fluids were also tested in
suckling mice. The fluid overlays obtained in passage of these 7 viruses on
human amnion or in monkey renal cell cultures likewise failed to cause
CPE on KB, HeLa, renal, and testicular cell cultures derived from
monkeys, and mouse embryo tissue cultures. The results of these tests are
recorded in Table 8.
OTHER TESTS IN TISSUE CULTURES AND SUCKLING MICE
Fluids harvested from infected monkey kidney and mouse embryo cells
were also passed on human amnion cells; similarly, fluids harvested from
HeLa, KB, monkey testicular, and mouse embryo cells were repassed on
monkey renal cells. In this way evidence of viral multiplication in monkey
renal cells was obtained for types 10, 14, and 16 when the fluid overlays
were passed in human amnion fluid. Subsequently these viruses con-
sistently produced CPE in monkey renal cells.
The type 1 virus after 5 passages on mouse embryonic tissue cultures,
and the type 6 virus after 8 passages on amnion cells, even in the absence
of CPE, produced illness and death in suckling mice. The type 1 virus
produced paralysis and death in 35 suckling mice; extracts from carcasses
of these mice produced a similar fatal illness. Although inoculation of
suckling mice with fluid overlays from 4th, 7th, and 8th passages of type 6
produced illness and death (31/63 mice), segmental limb paralysis of ques-
tionable nature was either transient in duration or was not observed. Ex-
tracts prepared from carcasses of mice which had developed illness after
inoculation with fluid overlays obtained from amnion cells (type 6 virus)
on further subinoculation produced a paralytic type of illness causing death
of mice.
The use of immunofluorescence for demonstration of virus multiplication
in cultures of cells which failed to show CPE did not reveal the presence
of labelled virus antigens. None of the 7 serotypes following "blind"
passages on mouse embryonic or on human amnion cells was specifically
labelled. Preliminary studies using the indirect method of immunofluores-
cence has not exposed intracellular virus particles for type 1 grown on
mouse embryonic, or for type 6 grown on human amnion cells.
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TABLE 8. PASSAGE OF 23 GROUP A COXSACKIE VIRUSES FOLLOWING
FOUR OR MoRE TRANSFERS ON PRIMARY AMNION OR MONKEY KIDNEY
CELLS IN SEVERAL OTHER
AND IN SUCKLING MICE
KINDS OF TISSUE CULTURE
Passaged primarily in
amnion MK
and repassaged in
Mo M
SM Embr testis KB HeLa
1 0 0
2 0 0
3 + 0
4 0 0
5 0 0
6 0 0
8 + 0
10 + +
11 + 0
12 + +
13 + 0
14 + +
15 + 0
16 + +
17 + 0
18 + 0
19 0 0
20 + 0
20a + 0
20b + 0**
21 + 0
22 0 0
24 + 0
0 0 0 0** 0 0
0 ±i 0 -4- 0 0
0 + 0 0** 0 0
0 0 0** 0 0
0 0 0 ndt 0 0
0 + 0 0 0 0
0 ±- 0 0 0 0
0 nd 0 nd nd nd
0 O " " "
0 + 0 " " "
0 nd 0 " "
nd + nic "i
nd
I
0 + 0 0 0 0
0 nd 0 nd nd nd
0 0 0 0 0 0
0 nd 0 0 nd nd
0 0 0 O "
0 0 0
it
0 " 0 0**
IV if
0 0 + 0 " 0
0 0 0** 0 0
*Abbreviations: CPE, cytopathic effect; MK, monkey kidney; Mo Embr, mouse
embryo; SM, suckling mice; M, monkey; KB and HeLa established cell lines. Amnion
cells were primary outgrowths obtained from human amnionic membranes. Symbols:
0, 0/4 cultures showed CPE; +, 4/4 cultures showed CPE; ±, 2 or 3 of 4 cultures
showed questionable CPE.
** Probably negative although 1/4 cultures showed questionable CPE.
t nd, not done.
t Types 7, 9, and 23 are not entered in the table; they produce CPE on amnionic
and monkey renal cells; undiluted fluid overlays produce paralysis and death in
suckling mice.
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DISCUSSION
Our interest in propagating the Group A Coxsackie viruses in tissue
cultures was aroused when the University of Kansas was asked to prepare
type-specific antisera. At the start of the work in 1958 a study was made
to determine the number of prototypic strains which could be propagated on
cells cultivated in vitro. By that time several types (e.g., 7, 9, 20, 21, and
TABLE 9. THE PRESENCE OR ABSENCE OF VIRAL ANTIGENS IN
TISSUE CULTURES IN WHICH CPE WAS NOT REVEALED
Tested in suckling mice
Group A amnionic Mouse embryo
Coxsackie 4th 8th TC 4th Tested by immuno-
serotype passage passage passage* fluorescence
1 neg neg + 0
2 " +-** neg 0
4 " neg " 0
5 "** " "** 0
6 +? +? " 0
19 neg neg " 0
22 0 " "
14 + nd nd +
* Mouse embryo TC, 4th and 5th passage fluid overlays (type 1 virus) produced
paralysis and death in 3 independent tests (death rate 35/35). Type 6 fluid overlays
between the 4th and 8th passages killed 31/63 mice in 4 independent tests.
** Scattered deaths without observance of paralysis, deaths were usually -30 per
cent of litter; occasionally an entire litter died or was cannibalized during the first
10 days after inoculation. The type 14 virus was cytopathic on amnion cells (see Table
6); it was used as a positive control in these tests.
23) were known to cause CPE on primate cells (2, 3, 7, 9, 10). Syverton
and his associates were studying the problem too; we received types 10, 11,
13, 15, 16, and 18 viruses adapted to human amnion cells"'0' from the
University of Minnesota laboratories.* Subsequently, as reported in this
paper we were able to propagate not only the same serotypes as they did,
* The late J. T. Syverton sent us all prototypic Group A strains which he and his
associates cultivated in amnion cells. He also sent us type-specific antisera which he
and his associates had prepared. The early experiences with these reagents were of
material help in pilot studies preliminary to the final steps in antiserum production.
We are grateful for this assistance. Later we obtained corresponding serotypes from
Dr. Plager. The tissue culture "adapted" viruses reported here represent stocks
obtained in this laboratory with prototypic mouse-adapted viruses.
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but to add 5 more, namely types 3, 8, 12, 17, and 241 to the list of Group
A viruses propagable on primate cells in culture.
The addition of 5 new serotypes to the 12 previously known to be cyto-
pathic leaves 7 Group A viruses which in our studies have not yielded CPE
in tissue cultures. Undoubtedly these 7 serotypes, when conditions are ful-
filled, will be propagable in tissue cultures. Several possible explanations
might apply to these rejections. First, the virus population maintained con-
tinually in mice for many passages could have provided a population of
viruses with very limited tropism for primate cells. We obtained several
serotypes recently recovered from human beings; these strains had been
passed only a few times in mice. They also failed to produce CPE. More-
over, all these viruses rejected mouse embryonic cells, just as they had
primate cells. Another explanation, suggested by the implicit evidence
obtained for latent infection with type 1 virus in mouse cells, and pos-
sibly for type 6 virus in amnion cells, is that some factor may be missing
in the substrate which is essential for maximal growth and cytopatho-
genicity of these viruses. These singular viruses may form a stratum within
the Group A complex requiring an essential but still unrecognized metabo-
lite.' Certainly for serotypes such as type 3 some unknown requirement had
to be fulfilled during passage before complete CPE was achieved.
Several of our Group A viruses following serial passage in amnion cells
were less virulent for mice than the infected mouse tissues from which they
were derived. When comparable virus preparations from cultures at dif-
ferent passage levels were titrated in mice the gain in infectivity for the
culture system was associated with a decreased pathogenicity for mice. Our
results were very similar to those obtained by Lehmann-Grube and Syver-
ton.' These authors, on the basis of more extensive observations than ours
believe that during "adaptation" mutations which occur at a high rate lead
to variants with decreased mouse virulence and increased tropism for cells
in cultures. Our studies do not add further insight into the phenomena
responsible for these qualitative changes in viral character.
A greater effort was made to obtain CPE with amnion than with other
primate cells entered in the study. Human amnion cells had been success-
fully used before. The other cell lines were used with differing frequencies:
those less frequently used (e.g., human skin and kidney) were less readily
obtainable than others. When it became evident that amnion cells were
more sensitive to CPE than other cell lines, further passages in the latter
systems were often discontinued. These different systems were utilized
however for more extensive studies among the 7 serotypes not yet yielding
CPE.
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The use of tissue cultures for studies with the Coxsackie viruses has
advantages over the use of suckling mice. Studies on epidemiology and
pathogenesis can be implemented and expanded. Antigens obtained in fluid
overlay can be used in neutralization and very probably in complement
fixation tests. Viruses, "adapted" to tissue cultures retain serological
specificity and thereby facilitate assay measurements in serological studies.
The system partially eliminates the use of suckling mice for many biological
determinations. The latter system is fraught with difficulties in bio-assays.
But it would be unwise to predict that suckling mice will be eliminated in
all studies for as yet this living organism appears to be more sensitive than
amnion or monkey renal cells cultured in vitro for the detection on
primary passage of many Group A viruses present in feces and other body
exudates.
SUMMARY
Of the serotypic Group A Coxsackie viruses, representing the prototypes
catalogued by Dalldorf and Sickles,'1' 17 have been propagated in tissue
culture. All but one of these 17 strains produced CPE in primary human
amnion cells; the one strain (type 7) which thus far has failed to affect
amnion cells produced CPE in renal cells obtained from monkeys. Several
of these 17 viruses also produced cytopathic changes on human kidney
and skin, and on HeLa, KB, and monkey renal and testicular cells. Among
these 17 Group A viruses there are 5 serotypes which have been identified
recentlyl' as capable of causing CPE in tissue cultures. A total of 7 sero-
types presently listed among the prototypic Group A Coxsackie viruses
were not associated with cytopathic changes following at least 4 passages
in 9 tissue culture systems. Type 1 virus and possibly type 6 virus may
have propagated without producing CPE in several independent cultural
systems. However, additional studies are necessary in order to eliminate
seriate carry-over of residual virus.
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